Ads
related to: maintenance therapy for bladder cancer side effects- Resources & Support
For Patient And Caregiver
Learn More.
- Financial Support
Find Info On Financial Support
For Eligible Patients. Learn More.
- Safety Information
Important Safety Info And More
On The Official Patient Site.
- FAQs
Find FAQs For This Treatment Option
On The Official Patient Site.
- Resources & Support
Search results
Results from the WOW.Com Content Network
Cisplatin and gemcitabine treatment may be associated with less severe side effects. [5] Up to half of people with bladder cancer are not able to take these chemotherapy treatments due to their overall health. Taxanes or vinflunine have been used as second-line therapy (after progression on a platinum containing chemotherapy). [16]
The term "induction regimen" refers to a chemotherapy regimen used for the initial treatment of a disease. A " maintenance regimen " refers to the ongoing use of chemotherapy to reduce the chances of a cancer recurring or to prevent an existing cancer from continuing to grow.
Nausea and vomiting are two of the most feared cancer treatment-related side-effects for people with cancer and their families. In 1983, Coates et al. found that people receiving chemotherapy ranked nausea and vomiting as the first and second most severe side-effects, respectively. [98]
The US Food and Drug Administration (FDA) approved durvalumab for certain types of bladder, lung, and biliary tract cancer: [6] [13] [14]. Adults with locally advanced or metastatic urothelial carcinoma who either have disease progression during or following platinum-containing chemotherapy or have disease progression within twelve months of neoadjuvant or adjuvant treatment with platinum ...
Bladder cancer is most common in wealthier regions of the world, where exposure to certain carcinogens is highest. It is also common in places where schistosome infection is common, such as North Africa. [47] Bladder cancer is much more common in men than women; around 1.1% of men and 0.27% of women develop bladder cancer. [2]
Dmitry Walker, assistant director of pharmacy oncology and investigational drug services at WVU Medicine, said his institution would love to offer a trial for people with bladder cancer using ...
The safety and effectiveness of nadofaragene firadenovec was evaluated in a multicenter clinical study (Study CS-003 (NCT02773849)) that included 157 participants with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle-invasive bladder cancer, 98 of whom had BCG-unresponsive carcinoma in situ with or without papillary tumors and could be evaluated for response.
Maintenance therapy is a medical therapy that is designed to help a primary treatment succeed. [1] For example, maintenance chemotherapy may be given to people who have a cancer in remission in an attempt to prevent a relapse. [ 2 ]
Ads
related to: maintenance therapy for bladder cancer side effects